|
‘Current
US laws allow drug companies to patent inventions forever’
Mark Pohl is a registered patent attorney with Licensing
Law, a US law firm dealing with patent applications,
infringement opinions and licensing.
|
A Good Beginning
EDIT
ARTICLE
Risk
benefit assessment of APC
In the second part of the article, Dr Krishan Maggon
deals with the marketing, problems and challenges concerning
activated protein C for the treatment of severe sepsis
|
|
Queries
on GCP
Dr Arun D Bhatt, well known clinical pharmacologist
from Mumbai, answers your questions on Good Clinical
Practices.
|
Managing
risks in biotech industry
An optimal risk management system would identify
new risks as well as manage their financial impact in
a cost-effective manner, says Arun Kohli
|
